Markets
AnaptysBio, Inc. (ANAB)
ANABNASDAQ-GSBiotechnology: Pharmaceutical Preparations
$47.97
+1.52 (+3.27%) today
Closed, Nov 9, 4:00 PM ET
+3.27% 1D
- Market cap
- $1.42bn
- P/E
- 319.8
- EPS, last 4 quarters
- $0.1500
- Dividend yield
- –
- Day range
- –
- 52-week range
- $30.27 to $73.30
- Average volume
- 510.1k
- Previous close
- $46.45
Analysts
7 coveringBuy6 buy, 1 hold, 0 sell
Targets a year out average $77.40, +61.4% from here
$60.00now $47.97$95.00
Earnings
next estimate $0.4100Next report Nov 10, 2026
Sep 2025
+149.1%
Dec 2025
+77.5%
Mar 2026
-475.0%
Jun 2026
+76.1%
estimate reported, and the surprise
Financials
| Quarter | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|
| Revenue | $9.01m | $7.18m | $10.97m | $30.02m |
| Gross profit | $9.01m | $7.18m | $10.97m | $30.02m |
| Operating income | -$42.13m | -$42.20m | -$40.32m | -$22.76m |
| Net income | -$42.21m | -$43.94m | -$46.66m | -$32.85m |
Last four quarters: revenue $57.17m, margin -289.8%, free cash flow -$103.39m
News
8 latest- Arcutis Biotherapeutics, Inc. (ARQT) Reports Next Week: Wall Street Expects Earnings GrowthZacks · Oct 28, 2026
- AnaptysBio, Inc. (ANAB) Expected to Beat Earnings Estimates: Should You Buy?Zacks · Oct 27, 2026
- CytoDyn Appoints Robert E. Hoffman As CEO; Lalezari To Focus On Research RTTNews · Oct 20, 2026
- GSK's Jemperli Becomes First Approved Immunotherapy For MSI-H/dMMR Locally Advanced Renal Cancer RTTNews · Oct 19, 2026
- AnaptysBio Swings To Profit In Q2 Reflecting $181.5 Mln Tax Benefit RTTNews · Sep 22, 2026
- AnaptysBio, Inc. (ANAB) Reports Q2 Loss, Tops Revenue EstimatesZacks · Sep 21, 2026
- GSK's sBLA for Jemperli Gets FDA Priority Tag in Rectal CancerZacks · Aug 24, 2026
- CorMedix (CRMD) Q2 Earnings and Revenues Top EstimatesZacks · Aug 13, 2026
The company
Anaptys manages the financial collaborations for Jemperli with GSK and Quimilza with Vanda, with a focus on protecting and returning the value of its royalties to shareholders.
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Exchange
- NASDAQ-GS
- Region
- North America
- Website
- anaptysbio.com
Often looked at with it
Figures from Yahoo, Nasdaq (Zacks consensus) and Lighter. Stocks can be minutes behind. Nothing here is advice.